November 28, 2014 1:20 AM ET

Healthcare Equipment and Supplies

Company Overview of NeoVista, Inc.

Company Overview

NeoVista, Inc., a medical device company, develops medical technologies for use in the treatment of wet age-related macular degeneration that causes blindness in men and women over the age of 50 years. It develops VIDION ANV Therapy system that is offered as an adjunct therapy to anti-VEGF injections for the treatment of neovascular age-related macular degeneration. The company was founded in 2002 and is based in Newark, California.

38875 Cherry Street

Newark, CA 94560

United States

Founded in 2002

Phone:

510-933-7600

Fax:

510-933-7659

Key Executives for NeoVista, Inc.

Chief Executive Officer
Age: 62
Vice President of Finance
Vice President of R&D & Operations
Age: 54
Vice President of Medical and Clinical Affairs
Vice President of Information Technology
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Next Health, LLC United States
Olympus America Inc. United States
Inspire Medical Systems, Inc. United States
CIRCA Scientific, LLC United States
CAO Group, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NeoVista, Inc., please visit www.neovistainc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.